Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

NCT02843386 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

302

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma

Interventions

DRUG: Adjuvant chemotherapy by Fotemustin
OTHER: Intensive surveillance

Sponsor

Institut Curie

Collaborators

[object Object]
[object Object]